We also found associations between tumor location, tumor focality/centricity, hormone receptor expression, cellular proliferation, and Oncotype DX® Breast Cancer Assay Recurrence Score® and performance for one or more cognitive function composite domains. The gene discussed is NR4A1; the disease is breast carcinoma.